SMAD2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.50484094471904E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29320000263888E-08 |
Normal-vs-Stage2 |
1.179260E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.056130E-02 |
Stage1-vs-Stage2 |
5.802200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.821800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.001200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.46810033416511E-10 |
Normal-vs-AfricanAmerican |
1.784180E-01 |
Normal-vs-Asian |
3.661600E-02 |
Caucasian-vs-AfricanAmerican |
5.345800E-01 |
Caucasian-vs-Asian |
9.432600E-01 |
AfricanAmerican-vs-Asian |
4.552200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.59810000000182E-05 |
Normal-vs-Female |
6.31330000500085E-08 |
Male-vs-Female |
4.193400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.177900E-04 |
Normal-vs-Extreme_Weight |
2.93490000002894E-06 |
Normal-vs-Obese |
1.223790E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.747230E-01 |
Normal_Weight-vs-Obese |
5.677800E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.885600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.804570E-01 |
Normal-vs-Age(41-60Yrs) |
1.85480000003402E-06 |
Normal-vs-Age(61-80Yrs) |
3.25609999962673E-07 |
Normal-vs-Age(81-100Yrs) |
3.536400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.662060E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.306420E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.559600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.430200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.889600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.372400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.171600E-01 |
Normal-vs-Grade 3 |
6.677000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.833610E-01 |
Grade 2-vs-Grade 4 |
9.171600E-01 |
Grade 3-vs-Grade 4 |
6.677000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.05339975525953E-10 |
Normal-vs-N1 |
1.906170E-02 |
N0-vs-N1 |
1.567580E-01 |
|
|